REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Libra-Med Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: LIBRA-MED Gyogyszereszeti Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Libra-Med Bt. is an enterprise based in Hungary. Its main office is in Izsak. It operates in the Pharmacies and Drug Stores industry. The company was established on May 09, 2006. There are currently 8 (2024) people employed by Libra-Med Bt.. In 2023, the company reported a net sales revenue increase of 13.62%. Its’ total assets recorded a growth of 65.02%. Libra-Med Bt.’s net profit margin increased by 5.35% in 2023.

Headquarters
Rakoczi utca 2.
Izsak; Bacs-Kiskun; Postal Code: 6070

Contact Details: Purchase the Libra-Med Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Libra-Med Bt. report to view the information.
Outstanding Shares:
Purchase the Libra-Med Bt. report to view the information.
Registered Capital:
Purchase the Libra-Med Bt. report to view the information.
Financial Auditors:
Purchase the Libra-Med Bt. report to view the information.
Incorporation Date:
May 09, 2006
Key Executives
Purchase this report to view the information.
Executive Officer
Purchase this report to view the information.
Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Libra-Med Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
13.62%▲
Total operating revenue
14.08%▲
Operating profit (EBIT)
51.04%▲
EBITDA
47.53%▲
Net Profit (Loss) for the Period
88.92%▲
Total assets
65.02%▲
Total equity
14.7%▲
Operating Profit Margin (ROS)
2.62%▲
Net Profit Margin
5.35%▲
Return on Equity (ROE)
16.31%▲
Quick Ratio
0.85%▲
Cash Ratio
-0.3%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo